Matti Narkia's Library tagged → View Popular
Depression as a predictor for coronary heart disease: a review and meta-analysis1
Depression as a predictor for coronary heart disease. a review and meta-analysis.
Rugulies R.
Am J Prev Med. 2002 Jul;23(1):51-61. Review.
PMID: 12093424
NEJM -- Coronary Calcium as a Predictor of Coronary Events in Four Racial or Ethnic Groups
Coronary calcium as a predictor of coronary events in four racial or ethnic groups.
Detrano R, Guerci AD, Carr JJ, Bild DE, Burke G, Folsom AR, Liu K, Shea S, Szklo M, Bluemke DA, O'Leary DH, Tracy R, Watson K, Wong ND, Kronmal RA.
N Engl J Med. 2008 Mar 27;358(13):1336-45.
PMID: 18367736
Prospective Study of Predictors of Vitamin D Status and Cancer Incidence and Mortality in Men -- Giovannucci et al. 98 (7): 451 -- JNCI Journal of the National Cancer Institute
Prospective study of predictors of vitamin D status and cancer incidence and mortality in men.
Giovannucci E, Liu Y, Rimm EB, Hollis BW, Fuchs CS, Stampfer MJ, Willett WC.
J Natl Cancer Inst. 2006 Apr 5;98(7):451-9.
PMID: 16595781
doi:10.1093/jnci/djj101
Conclusions: Low levels of vitamin D may be associated with increased cancer incidence and mortality in men, particularly for digestive-system cancers. The vitamin D supplementation necessary to achieve a 25(OH)D increment of 25 nmol/L may be at least 1500 IU/day.
Small, Dense Low-Density Lipoprotein Particles as a Predictor of the Risk of Ischemic Heart Disease in Men: Prospective Results From the Quebec Cardiovascular Study -- Lamarche et al. 95 (1): 69 -- Circulation
Conclusions These results represent the first prospective evidence suggesting that the presence of small, dense LDL particles may be associated with an increased risk of subsequently developing IHD in men. Results also suggest that the risk attributed to small LDL particles may be partly independent of the concomitant variation in plasma lipoprotein-lipid concentrations.
Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study.
Lamarche B, Tchernof A, Moorjani S, Cantin B, Dagenais GR, Lupien PJ, Després JP.
Circulation. 1997 Jan 7;95(1):69-75.
PMID: 8994419
NEJM -- C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.
Ridker PM, Hennekens CH, Buring JE, Rifai N.
N Engl J Med. 2000 Mar 23;342(12):836-43.
PMID: 10733371
Future adverse cardiac events can be predicted by persistently low plasma adiponectin concentrations in men and marked reductions of adiponectin in women after acute myocardial infarction
Future adverse cardiac events can be predicted by persistently low plasma adiponectin concentrations in men and marked reductions of adiponectin in women after acute myocardial infarction.\nKojima S, Funahashi T, Otsuka F, Maruyoshi H, Yamashita T, Kajiwara I, Shimomura H, Miyao Y, Fujimoto K, Sugiyama S, Sakamoto T, Yoshimura M, Ogawa H.\nAtherosclerosis. 2007 Sep;194(1):204-13. Epub 2006 Sep 12.\nPMID: 16970953 \ndoi:10.1016/j.atherosclerosis.2006.07.028\n
Leptin, but not adiponectin, is a predictor of recurrent cardiovascular events in men: results from the LIPID study - International Journal of Obesity - Abstract of article
Leptin, but not adiponectin, is a predictor of recurrent cardiovascular events in men: results from the LIPID study.
Söderberg S, Colquhoun D, Keech A, Yallop J, Barnes EH, Pollicino C, Simes J, Tonkin AM, Nestel P; LIPID Study Investigators.
Int J Obes (Lond). 2009 Jan;33(1):123-30. Epub 2008 Dec 9.
PMID: 19050671
Plasma adiponectin and resistin levels as predictors of mortality in patients with acute myocardial infarction: data from infarction prognosis study registry. - .[Coron Artery Dis. 2009] - PubMed Result
Plasma adiponectin and resistin levels as predictors of mortality in patients with acute myocardial infarction: data from infarction prognosis study registry.
Lee SH, Ha JW, Kim JS, Choi EY, Park S, Kang SM, Choi D, Jang Y, Chung N.
Coron Artery Dis. 2009 Jan;20(1):33-9.
PMID: 18997620
PSA is poor predictor of lethal prostate cancer
The amount of prostate-specific antigen (PSA) in a man’s bloodstream at the time of his prostate cancer diagnosis or its rate of change over the course of the disease does not adequately predict lethal prostate cancer, according to a study in the April
Selected Tags
Related Tags
Sponsored Links
Top Contributors
Groups interested in predictor
Diigo is about better ways to research, share and collaborate on information. Learn more »
Join Diigo
